Anika Therapeutics Inc (ANIK)
16.97
-0.46
(-2.64%)
USD |
NASDAQ |
Nov 22, 16:00
17.02
+0.05
(+0.29%)
After-Hours: 20:00
Anika Therapeutics Enterprise Value: 186.17M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 186.17M |
| November 21, 2024 | 192.90M |
| November 20, 2024 | 189.24M |
| November 19, 2024 | 187.19M |
| November 18, 2024 | 187.19M |
| November 15, 2024 | 190.27M |
| November 14, 2024 | 186.61M |
| November 13, 2024 | 187.19M |
| November 12, 2024 | 184.85M |
| November 11, 2024 | 187.63M |
| November 08, 2024 | 190.42M |
| November 07, 2024 | 189.98M |
| November 06, 2024 | 190.56M |
| November 05, 2024 | 176.36M |
| November 04, 2024 | 187.63M |
| November 01, 2024 | 179.72M |
| October 31, 2024 | 188.22M |
| October 30, 2024 | 299.09M |
| October 29, 2024 | 296.74M |
| October 28, 2024 | 298.79M |
| October 25, 2024 | 294.99M |
| October 24, 2024 | 297.78M |
| October 23, 2024 | 298.22M |
| October 22, 2024 | 300.57M |
| October 21, 2024 | 296.75M |
| Date | Value |
|---|---|
| October 18, 2024 | 305.86M |
| October 17, 2024 | 307.19M |
| October 16, 2024 | 308.07M |
| October 15, 2024 | 307.19M |
| October 14, 2024 | 309.98M |
| October 11, 2024 | 310.57M |
| October 10, 2024 | 308.66M |
| October 09, 2024 | 312.77M |
| October 08, 2024 | 299.69M |
| October 07, 2024 | 295.43M |
| October 04, 2024 | 304.84M |
| October 03, 2024 | 309.10M |
| October 02, 2024 | 305.28M |
| October 01, 2024 | 294.26M |
| September 30, 2024 | 300.57M |
| September 27, 2024 | 300.58M |
| September 26, 2024 | 301.62M |
| September 25, 2024 | 302.51M |
| September 24, 2024 | 302.80M |
| September 23, 2024 | 307.39M |
| September 20, 2024 | 314.49M |
| September 19, 2024 | 312.42M |
| September 18, 2024 | 314.05M |
| September 17, 2024 | 310.05M |
| September 16, 2024 | 305.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
132.14M
Minimum
Mar 18 2020
659.70M
Maximum
Nov 25 2019
358.61M
Average
342.62M
Median
Nov 29 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
| Xtant Medical Holdings Inc | 83.10M |
| Myomo Inc | 147.33M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.92M |
| Revenue (Quarterly) | 38.75M |
| Total Expenses (Quarterly) | 63.67M |
| EPS Diluted (Quarterly) | -2.03 |
| Gross Profit Margin (Quarterly) | 3.72% |
| Profit Margin (Quarterly) | -77.20% |
| Earnings Yield | -39.19% |
| Normalized Earnings Yield | -13.27 |